We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Bill Prohibits FDA Interference in ‘Right to Try’ Process
Senate Bill Prohibits FDA Interference in ‘Right to Try’ Process
Despite the FDA approving more than 99 percent of expanded access requests and offering emergency access authorization, a Senate committee chairman introduced legislation Tuesday that prohibits the FDA from interfering in the prescribing of investigational drugs to terminally ill patients.